Recently, Lingjie Aviation (Infini Aero, unlisted) closed a RMB 10 million-level angel round solely funded by Shanghai Huxiang Investment; terms undisclosed.
On 12 Nov 2026, MEIG (03268.HK) said associate HOSIN ELEC (02681.HK) listed in Hong Kong at HKD 72.83; its stake may lift 2026 profit by RMB 88.47 million.
On 12 Nov 2026, CHINA POWER (02380.HK) said it issued a second RMB 1.5 billion perpetual medium term note tranche in China on 11 November at a 1.73% coupon.
On 12 Nov 2026, FOSUN PHARMA (02196.HK) said unit Fosun Kite began a Phase II trial of FKC516, a CD20 CAR-T therapy, in relapsed B-cell NHL in the PRC.
On November 12, the HSI fell 1.26% and the HSTECH 2.36%. TRANSSION led Stock Connect gainers at 22.47% as southbound funds bought HK$5.846 billion net.
On November 12, the HSI fell 1.26% and the HSTECH 2.36% as chip names bucked the trend; ILUVATAR COREX rose 8.85%, while 17 of 20 AI concept stocks declined.
On November 12, 2026, AMICRO topped the gainers with a rise of 38.18%; Z.AI led liquidity with turnover of HKD 3.801 billion; METIS TECHBIO-P and IMPACT THERAP-B will see lock-up expiries tomorrow.
On November 12, Hong Kong stocks retreated, the Hang Seng Index down 1.26% on turnover of 202.7 billion HKD and southbound net buying of 5.846 billion HKD.
On November 12, 2026, liquor staged a reversal in the Hong Kong ETF market while technology hardware pulled back broadly. E Fund (HK) CSI Liquor Index ETF (03189.HK) rose 4.76% to lead just one day after a 7.80% slide, with no top-ten gain exceeding 4.76%; Bosera SZSE ChiNext Daily (2x) Leveraged Product (07234.HK) fell 5.10% to lead decliners, with no top-ten loss smaller than 2.69%, and only two of 41 Southbound (Stock Connect) ETFs rose.
On the 11th, ASCLETIS-B (01672.HK) submitted to the FDA an Investigational New Drug (IND) application for the world's first oral GLP-1 and amylin combination obesity drug. Mrs. Wu, an executive director of the Company, holds approximately 7.75% of the Company's interests through two discretionary trusts, while founder Dr. Wu separately holds 45.94% through a wholly owned BVI company.
ChinaAMC HK-US AI ETF (03140.HK) fell 1.55% to HK$6.675 as Hong Kong tech slid 2.04%, outweighing a 5.7% overnight gain in the SOX.
E Fund (HK) CSI Liquor Index ETF (03189.HK) jumped 5.47% to HK$1.196, closing a 4.66% discount as JD 11.11 liquor sales rose 25% and Moutai 10%.
GIANT BIOGENE (02367.HK) fell 4.51% to HKD 20.340 on Nov 12; Fan Daidi holds 55.13% via the FY Family Trust, and H1 revenue fell 6.3% to RMB 2.918 billion.
IFBH (06603.HK) traded at HKD 3.350 on Nov 12, up 0.60%; it left Stock Connect on Sep 7, with 175 million shares unlocked on June 30 and H1 revenue down 46.7%.
HUA HONG GRACE rose 2.06% to HKD 76.700 on 12 November 2026; Wuxi Phase III capital rose to USD 4.17 billion and STMicroelectronics set a fourth price rise.
EXCELLAND ROBOT fell 0.87% to HKD 34.180 on 12 November 2026; UBTECH will supply 400 U1 Pro robots to YONGDA AUTO and Beijing set a 2028 robot target.
